EUVIMEDEUVIMED entdecken
Crossref

Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations

Karina W. Davidson, Ying Kuen Cheung, Thomas McGinn, Y. Claire Wang

NAM Perspectives · 10.12.2018

DOI: 10.31478/201812d ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAM Perspectives, online erschienen am 10.12.2018. Verfasst von Karina W. Davidson und 3 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterogeneous responses to the same therapy among individual patients are commonplace in both biomedical research and patient care. Despite being considered by many as the pinnacle of the evidence-based […]

Förderung

  • National Institutes of Health

Zitieren

APA

Davidson, K. W., Cheung, Y. K., McGinn, T., & Wang, Y. C. (2018). Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations. NAM Perspectives. https://doi.org/10.31478/201812d

Vancouver

Davidson KW, Cheung YK, McGinn T, Wang YC. Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations. NAM Perspectives. 2018. doi:10.31478/201812d

BibTeX
@article{Davidson2018,
  author = {Davidson, Karina W. and Cheung, Ying Kuen and McGinn, Thomas and Wang, Y. Claire},
  title = {Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations},
  journal = {NAM Perspectives},
  year = {2018},
  doi = {10.31478/201812d}
}
Kostenlos starten →